Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
With
UnitedHealth Group
Age
65–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\>=2 International Statistical Classification of Diseases and Related Health Problems (ICD)-10-CM diagnosis codes for COPD at least 30 days apart during the 12 month period prior to sample identification.
Diagnosis codes J40-J44 will be included.
\>=1 pharmacy claim for UMEC/VI or FLUT/SAL single-inhaler dual therapy during Baseline.
Age \>= 65 years.
Self-reported health care provider diagnosis of COPD.
Self-reported prescription for FLUT/SAL or UMEC/VI.
12 months of continuous enrollment during the Baseline period.
Ability to complete the study survey in English.
You may not be if
\>=2 ICD-10-CM diagnosis codes for asthma at least 30 days apart during the, 12 month period, prior to sample identification.
Claims for both UMEC/VI and FLUT/SAL in the 6 months, closest to sample identification.
Claims for triple therapy (Inhaled Corticosteroid \[ICS\] + Long-acting Antimuscarinic \[LAMA\] + Long-acting Beta-agonist \[LABA\] during the Baseline period.
Evidence of lung cancer diagnosis and/or treatment
Clareo Health | Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness
